Physician
Oncology
Dr. Frederick Locke, MD
|
|
Give Review
Dr. Frederick Locke works in the field of Oncology. He studied medicine at Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63/85 in Research/PrimaryCare. He received awards:"Miles for Moffitt Scientist Award", "Internal Research Grant Award Recipient", "Clinical Research Training Institute Participant", "Young Investigator Award" and "Award for Molecular and Translational Research". Frederick Locke is also a published doctor. He has 8 paper published. The most recent paper is: Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experie...
Publications
- Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic Cell transplantation: a single institution experie...
- Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft vs. host Disease: Phase I trial results.
- Merkel cell Carcinoma and immunosuppression: what we still need to know.
- Myeloablative Intravenous Pharmacokinetically Targeted Busulfan Plus Fludarabine As Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With Non...
- Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic Cell transplanta...
- Conditional Deletion of PTEN in Peripheral T Cells Augments TCR-Mediated Activation but Does Not Abrogate CD28 Dependency or Prevent Anergy Induction.
- Phase II study of CD4+guided pentostatin lymphodepletion and pharmacokinetically-targeted busulfan as conditioning for hematopoietic Cell allografting.
Schools
Wayne State Univ Som
Fellow University Of Chicago Medical CenterHematologyOncology
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Immunotherapy
- Thoracentesis
Conditions Treated
- Carcinoma in Situ
- Lymphoma
- Lymphoma, Large Cell, Anaplastic
- Lymphoma, Large-Cell
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Miles for Moffitt Scientist Award
- Internal Research Grant Award Recipient
- Clinical Research Training Institute Participant
- Young Investigator Award
- Award for Molecular and Translational Research
Education
-
University of Chicago -
Wayne State University School of Medicine
Hospital
-
H. Lee Moffitt Cancer Center and Research Institute
Drug Facts
| NPI NUMBER | 1518129121 | |
| NPPES Provider LastName | LOCKE | |
| NPPES Provider FirstName | FREDERICK | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 145.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1518129121 |
| Last Name Of The Provider | LOCKE |
| First Name Of The Provider | FREDERICK |
| View All |
Similar Doctors
|
Dr. Jeff S. Russell, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ronald C. Deconti, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Alberto A. Chiappori, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mohamad A. Hussein, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Ragini Kudchadkar, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Mary C. Pinder-Schenck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Jones Jr., MD |
|
Dr. Gregory M. Springett, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|